Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
XBiotech financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.
Stock Price
$7.2
2024-10-29
Market Capitalization
$234.4 M
2024-10-29
Revenue
$4 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 03, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| Revenue | 4.0M | |||
| Cost of goods sold | 651.0K | |||
| Gross profit | 3.4M | |||
| Gross profit margin, % | 83.8% | |||
| General and administrative expense | 6.3M | 4.7M | 4.7M | 8.3M |
| Operating expense total | 37.8M | 37.5M | 42.5M | 55.7M |
| EBIT | (34.5M) | (37.5M) | (42.5M) | (55.7M) |
| EBIT margin, % | -860.1% | |||
| Investment income | 5.7M | |||
| Interest income | 3.8M | 10.4M | 9.8M | |
| Interest expense | 807.0K | 88.0K | ||
| Pre tax profit | (33.6M) | (24.3M) | (38.6M) | (45.3M) |
| Income tax expense | (688.0K) | 244.0K | (32.0K) | 235.0K |
| Net Income | (32.9M) | (24.6M) | (38.5M) | (45.5M) |
| EPS | (1.1) | (0.8) | (1.3) | (1.5) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |